{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:53:53Z","timestamp":1781308433475,"version":"3.54.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-023-02549-x","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T16:59:55Z","timestamp":1675961995000},"page":"1831-1836","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A randomized, open-label study to compare two different dosing regimens of oral tranexamic acid in treatment of moderate to severe facial melasma"],"prefix":"10.1007","volume":"315","author":[{"given":"Rajsmita","family":"Bhattacharjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Hanumanthu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Bishnoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keshavamurthy","family":"Vinay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davinder","family":"Parsad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthu Sendhil","family":"Kumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,9]]},"reference":[{"issue":"1","key":"2549_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0262833","volume":"17","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Zeng X, Ying J, Cai Y, Qiu Y, Xiang W (2022) Evaluating the quality of life among melasma patients using the MELASQoL scale: a systematic review and meta-analysis. PLoS ONE 17(1):e0262833","journal-title":"PLoS ONE"},{"key":"2549_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.713554","volume":"8","author":"Y Liu","year":"2021","unstructured":"Liu Y, Wu S, Wu H, Liang X, Guo D, Zhuo F (2021) Comparison of the efficacy of melasma treatments: a network meta-analysis of randomized controlled trials. Front Med (Lausanne) 8:713554","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"2549_CR3","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/DSS.0000000000001518","volume":"44","author":"HR Bala","year":"2018","unstructured":"Bala HR, Lee S, Wong C, Pandya AG, Rodrigues M (2018) Oral tranexamic acid for the treatment of melasma: a review. Dermatol Surg 44(6):814\u2013825","journal-title":"Dermatol Surg"},{"issue":"8","key":"2549_CR4","first-page":"E73","volume":"12","author":"JV Wang","year":"2019","unstructured":"Wang JV, Jhawar N, Saedi N (2019) Tranexamic acid for melasma: evaluating the various formulations. J Clin Aesthet Dermatol 12(8):E73\u2013E74","journal-title":"J Clin Aesthet Dermatol"},{"issue":"3","key":"2549_CR5","doi-asserted-by":"publisher","first-page":"e12465","DOI":"10.1111\/dth.12465","volume":"30","author":"M Taraz","year":"2017","unstructured":"Taraz M, Niknam S, Ehsani AH (2017) Tranexamic acid in treatment of melasma: a comprehensive review of clinical studies. Dermatol Ther. 30(3):e12465","journal-title":"Dermatol Ther."},{"key":"2549_CR6","first-page":"413","volume":"4","author":"H Leminen","year":"2012","unstructured":"Leminen H, Hurskainen R (2012) Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety. Int J Womens Health 4:413\u2013421","journal-title":"Int J Womens Health"},{"issue":"1","key":"2549_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jaad.2009.10.051","volume":"64","author":"AG Pandya","year":"2011","unstructured":"Pandya AG, Hynan LS, Bhore R, Riley FC, Guevara IL, Grimes P et al (2011) Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol 64(1):78\u201383 (e1\u20132)","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"2549_CR8","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1001\/jamadermatol.2016.1006","volume":"152","author":"M Rodrigues","year":"2016","unstructured":"Rodrigues M, Ayala-Cort\u00e9s AS, Rodr\u00edguez-Ar\u00e1mbula A, Hynan LS, Pandya AG (2016) Interpretability of the Modified Melasma Area and Severity Index (mMASI). JAMA Dermatol 152(9):1051\u20131052","journal-title":"JAMA Dermatol"},{"issue":"3","key":"2549_CR9","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1046\/j.1365-2133.2003.05419.x","volume":"149","author":"R Balkrishnan","year":"2003","unstructured":"Balkrishnan R, McMichael AJ, Camacho FT, Saltzberg F, Housman TS, Grummer S et al (2003) Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol 149(3):572\u2013577","journal-title":"Br J Dermatol"},{"issue":"2\u20133","key":"2549_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S1011-1344(98)00212-7","volume":"47","author":"K Maeda","year":"1998","unstructured":"Maeda K, Naganuma M (1998) Topical trans-4-aminomethylcyclohexanecarboxylic acid prevents ultraviolet radiation-induced pigmentation. J Photochem Photobiol B 47(2\u20133):136\u2013141","journal-title":"J Photochem Photobiol B"},{"issue":"5","key":"2549_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12704","volume":"31","author":"D Nagaraju","year":"2018","unstructured":"Nagaraju D, Bhattacharjee R, Vinay K, Saikia UN, Parsad D, Kumaran MS (2018) Efficacy of oral tranexemic acid in refractory melasma: a clinico-immuno-histopathological study. Dermatol Ther 31(5):e12704","journal-title":"Dermatol Ther"},{"issue":"2","key":"2549_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jaad.2017.09.053","volume":"78","author":"E Del Rosario","year":"2018","unstructured":"Del Rosario E, Florez-Pollack S, Zapata L Jr, Hernandez K, Tovar-Garza A, Rodrigues M et al (2018) Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma. J Am Acad Dermatol 78(2):363\u2013369","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2549_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/jocd.12291","volume":"16","author":"V Lajevardi","year":"2017","unstructured":"Lajevardi V, Ghayoumi A, Abedini R, Hosseini H, Goodarzi A, Akbari Z et al (2017) Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up. J Cosmet Dermatol. 16(2):235\u2013242","journal-title":"J Cosmet Dermatol."},{"issue":"2","key":"2549_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00403-020-02078-x","volume":"313","author":"B Chowdhary","year":"2021","unstructured":"Chowdhary B, Mahajan VK, Mehta KS, Chauhan PS, Sharma V, Sharma A et al (2021) Therapeutic efficacy and safety of oral tranexamic acid 250 mg once a day versus 500 mg twice a day: a comparative study. Arch Dermatol Res 313(2):109\u2013117","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"2549_CR15","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/jcpt.13430","volume":"46","author":"X Feng","year":"2021","unstructured":"Feng X, Su H, Xie J (2021) Efficacy and safety of tranexamic acid in the treatment of adult melasma: an updated meta-analysis of randomized controlled trials. J Clin Pharm Ther 46(5):1263\u20131273","journal-title":"J Clin Pharm Ther"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02549-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-023-02549-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02549-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T03:40:56Z","timestamp":1689219656000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-023-02549-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,9]]},"references-count":15,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["2549"],"URL":"https:\/\/doi.org\/10.1007\/s00403-023-02549-x","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,9]]},"assertion":[{"value":"4 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Yes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional ethical committee approval"}}]}}